ACTIDOM DA- chlorpheniramine maleate, phenylephrine hydrochloride solution 
Actipharma, Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

ACTIDOM® DA

Drug Facts

Active Ingredients (in each 5 mL tsp)

Chlorpheniramine Maleate, 1 mg

Phenylephrine HCL, 2.5 mg

Purposes

Antihistamine

Nasal Decongestant

Uses

• temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose  • sneezing  • itching of the nose or throat
• itchy, watery eyes  • nasal congestion
• temporarily restores free breathing through the nose

​Warnings

Do not use in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child's prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.

Ask a doctor before use if child has
• heart disease  • diabetes  • high blood pressure  • thyroid disease  • glaucoma  • a breathing problem such as chronic bronchitis

When using this productdo not exceed recommended dosage  
• excitability may occur, especially in children
• may cause drowsiness
• do not give this product to children who are taking sedatives of tranquilizers, without first consulting the child's doctor

Stop use and ask a doctor if  
• nervousness, dizziness, or sleeplessness occur
• symptoms do not improve within 7 days or are accompanied by fever. These could be signs of a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not take more than 6 doses in any 24-hour period.

 Children under 6 to under 12 years of age Take 2 teaspoon (10 mL), every 4 hours
 Children under 6 years of age Consult a doctor

Other information

• Store at controlled room temperature: 15°-30°C (59°-86°F).
• Tamper Evident Feature: Do not use if inner seal is torn, broken or missing.

Inactive ingredients

Citric acid, D&C Red 33, hydroxyethyl cellulose, flavor, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate and sucralose.

Questions or comments?

call weekdays from 8AM to 4PM AST at 1-787-608-0882

Contains the same active ingredients as Dometuss® - DA*

SUGAR & ALCOHOL FREE

Great Flavor

*Dometuss® DA is registered trademark of Domel Laboratories. This product is not manufactured, distributed or marketed by Domel Laboratories.

Manufactured in the USA for
ActiPharma, Inc. San Juan, PR 00917
www.actipharma.net

Packaging

IMAGE

ACTIDOM DA 
chlorpheniramine maleate, phenylephrine hydrochloride solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63102-115
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLORPHENIRAMINE MALEATE (UNII: V1Q0O9OJ9Z) (CHLORPHENIRAMINE - UNII:3U6IO1965U) CHLORPHENIRAMINE MALEATE1 mg  in 5 mL
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE2.5 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
WATER (UNII: 059QF0KO0R)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
Colorpink (LIGHT PINK) Score    
ShapeSize
FlavorBANANA, STRAWBERRYImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63102-115-16474 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/20/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34101/20/2022
Labeler - Actipharma, Inc (079340948)

Revised: 1/2022
Document Id: 42ab8014-a853-4d7a-a56d-5f4b96bbd9a5
Set id: 7797c22e-ffeb-4798-9fb6-aa64cf077ba7
Version: 1
Effective Time: 20220120
 
Actipharma, Inc